Purchase Order 75N95021P00371
Award Date
7/22/21
Potential Completion Date
7/21/22
Potential Value
$173K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Curi Bio Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $17,020 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Curi Bio Inc., a small disadvantaged business manufacturer. The contract is for the delivery of 3D IPSC skeletal muscle media kits, which will support biomedical research and drug development programs at NCATS. Curi Bio has previously received other federal contracts and grants from the National...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) has awarded a firm fixed-price purchase order contract to Curi Bio Inc., a self-certified small disadvantaged business, to provide a NanoSurface Cytostretcher Live-View System with post-warranty maintenance. This $62,390.00 contract, which was set aside for small businesses, has a completion date of December 3, 2024. Curi Bio is a for-profit corporation that develops human cell-based platforms to accelerate drug...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $17,760 firm fixed price purchase order to Curiox Biosystems Inc. of San Carlos, California. The period of performance for this contract is August 11, 2017 through August 10, 2018. Curiox Biosystems Inc. will serve as the prime contractor, providing unspecified products or services to NIH/NICHD in support of their research efforts. No major...
This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and...
This federal contract award, valued at $2,592,564.37, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc. (doing business as Amri), a leading global contract development and manufacturing organization (CDMO). The award is for a Delivery Order under the Biomedical Prototype Network - Medicinal Chemistry Support Program for Therapeutic Development (BPN-MCSP-HIT) to support chemistry-related services, including hit-to-lead chemistry, for the Martin...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $158,684.80 firm fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for maintenance services on a government-owned Bruker preclinical magnetic resonance imaging (MRI) system used by the NCI's Center for Cancer Research (CCR). The purchase order will enable Bruker, the original equipment manufacturer, to provide regular...
This $142,500 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a global contract development and manufacturing organization (CDMO). The contract is for sequencing services to identify molecules that bind the KIAA0203 protein, in support of the NIH's preclinical drug discovery efforts. No set-aside designation was used. Curia has provided...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Cell Microsystems Inc., a for-profit manufacturer of biomedical research equipment and supplies. The $205,600.00 contract is for the delivery of the CELLRAFT air system and CYTOSORT 100 instrument, which support various research applications such as gene editing, cancer research, and immunology. The contract does not have a set-aside designation. Cell...
This is a $3,349,436.46 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as AMRI. The contract is part of NINDS's Medicinal Chemistry Support Program for Therapeutic Development, which focuses on early-stage drug discovery research. The contract provides for exploratory chemistry and other pharmaceutical research and development services to support NINDS's scientific initiatives,...
This is a $3,453,835.19 delivery order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, a for-profit manufacturer. The contract is for the Medicinal Chemistry Support Program for Therapeutic Development, which provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry;...